Biomedical Engineering Reference
In-Depth Information
[89] Lim YB, Han SO, Kong HU, Lee Y, Park JS, Jeong B, et al. Biodegradable polyes-
ter, poly[-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. Pharm Res
2000;17:811-16.
[90] Koh JJ, Ko KS, Lee M, Han S, Park JS, Kim SW. Degradable polymeric carrier for the
delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice. Gene
Ther 2000;7:2099-104.
[91] Lee M, Koh JJ, Han SO, Ko KS, Kim SW. Prevention of autoimmune insulitis by deliv-
ery of interleukin-4 plasmid using a soluble and biodegradable polymeric carrier. Pharm
Res 2002;19:246-9.
[92] Ko KS, Lee M, Koh JJ, Kim SW. Combined administration of plasmids encoding IL-4
and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice.
Mol Ther 2001;4:313-16.
[93] Maheshwari A, Han S, Mahato RI, Kim SW. Biodegradable polymer-based interleukin-
12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in
anti-tumor activity. Gene Ther 2002;9:1075-84.
[94] Schmolka IR. A review of block copolymer surfactants. J Am Oil Chem Soc
1977;54:110-16.
[95] Nagarajan R. Solubilization of hydrocarbons and resulting aggregate shape transitions
in aqueous solutions of Pluronic ® (PEO-PPO-PEO) block copolymers. Colloids Surf B
1999;16:55-72.
[96] Kabanov AV, Batrakova EV, Melik-Nubarov NS, Fedoseev NA, Dorodnich TY, et al.
A new class of drug carriers: micelles of poly(oxyethylene)-poly (oxypropylene) block
copolymers as microcontainers for drug targeting from blood in brain. J Control Release
1992;22:141-57.
[97] Mahato R, Kawabata K, Nomura T, Takakura Y, Hashida M. Physiochemical and phar-
macokinetics of plasmid DNA/cationic liposome complexes. J Pharm Sci 1995;84:
1267-71.
[98] Verbaan FJ, Oussoren C, van Dam IM, Takakura Y, Hashida M, Crommelin DJ, et al.
The fate of poly (2-dimethyl amino ethyl)methacrylate-based polyplexes after intrave-
nous administration. Int J Pharm 2001;214:99-101.
[99] Hwang SJ, Davis ME. Cationic polymers for gene delivery: designs for overcoming
barriers to systemic administration. Curr Opin Mol Ther 2001;3:183-91.
[100] Astafieva L, Maksimova I, Lukanidin E, Alakhov V, Kabanov A. Enhancement of the
polycation-mediated DNA uptake and cell transfection with Pluronic ® P85 block copo-
lymer. FEBS Lett 1996;389:278-80.
[101] Cho CW, Cho YS, Lee HK, Yeom YI, Park SN, Yoon DY. Improvement of receptor-
mediated gene delivery to HepG2 cells using an amphiphilic gelling agent. Biotechnol
Appl Biochem 2000;32:21-6.
[102] Cho CW, Cho YS, Kang BT, Hwang JS, Park SN, Yoon DY. Improvement of gene trans-
fer to cervical cancer cell lines using non-viral agents. Cancer Lett 2001;162:75-85.
[103] Kuo JH. Effect of Pluronic ® -block copolymers on the reduction of serum-mediated inhi-
bition of gene transfer of polyethyleneimine-DNA complexes. Biotechnol Appl Biochem
2003;37:267-71.
[104] Gebhart CL, Sriadibhatla S, Vinogradov S, Lemieux P, Alakhov V, Kabanov AV. Design
and formulation of polyplexes based on pluronic ® -polyethyleneimine conjugates for
gene transfer. Bioconjugate Chem 2002;13:937-44.
[105] Jeon E, Kim HD, Kim JS. Pluronic ® -grafted poly-(L)-lysine as a new synthetic gene carrier.
J Biomed Mater Res 2003;66:854-9.
Search WWH ::




Custom Search